-
Bonnans C, Chou J, Werb Z, 2014: Remodelling the extracellular matrix in development and disease[J]. Nat Rev Mol Cell Biol, 15, 786-801.
-
Chen L, Liu R, Liu ZP, Li M, Aihara K, 2012: Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers[J]. Sci Rep, 2, 342-. doi: 10.1038/srep00342
-
Connors M, Giese NA, Kulkarni AB, Firestone CY, Morse HC 3rd, Murphy BR, 1994: Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10[J]. J Virol, 68, 5321-5325. doi: 10.1128/jvi.68.8.5321-5325.1994
-
Connors M, Kulkarni AB, Firestone CY, Holmes KL, Morse HC, Sotnikov AV, Murphy BR, 1992: Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells[J]. J Virol, 66, 7444-7451. doi: 10.1128/jvi.66.12.7444-7451.1992
-
Delgado MF, Coviello S, Monsalvo AC, Melendi GA, Hernandez JZ, Batalle JP, Diaz L, Trento A, Chang HY, Mitzner W, Ravetch J, Melero JA, Irusta PM, Polack FP, 2009: Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease[J]. Nat Med, 15, 34-41. doi: 10.1038/nm.1894
-
Durant LR, Makris S, Voorburg CM, Loebbermann J, Johansson C, Openshaw PJ, 2013: Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice[J]. J Virol, 87, 10946-10954. doi: 10.1128/JVI.01295-13
-
Graham BS, Bunton LA, Wright PF, Karzon DT, 1991: Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice[J]. J Clin Invest, 88, 1026-1033. doi: 10.1172/JCI115362
-
Gueders MM, Paulissen G, Crahay C, Quesada-Calvo F, Hacha J, Van Hove C, Tournoy K, Louis R, Foidart JM, Noel A, Cataldo DD, 2009: Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production[J]. Inflamm Res, 58, 845-854. doi: 10.1007/s00011-009-0054-2
-
Harker JA, Godlee A, Wahlsten JL, Lee DC, Thorne LG, Sawant D, Tregoning JS, Caspi RR, Bukreyev A, Collins PL, Openshaw PJ, 2010: Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells[J]. J Virol, 84, 4073-4082. doi: 10.1128/JVI.02014-09
-
Hori S, Nomura T, Sakaguchi S, 2003: Control of regulatory T cell development by the transcription factor Foxp3[J]. Science, 299, 1057-1061. doi: 10.1126/science.1079490
-
Huang W, Sherman BT, Lempicki RA, 2009: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources[J]. Nat Protocols, 4, 44-57. doi: 10.1038/nprot.2008.211
-
Jenner RG, Young RA, 2005: Insights into host responses against pathogens from transcriptional profiling[J]. Nat Rev Microbiol, 3, 281-294. doi: 10.1038/nrmicro1126
-
Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C, 2009: STRING 8: a global view on proteins and their functional interactions in 630 organisms[J]. Nucleic Acids Res, 37, 412-416. doi: 10.1093/nar/gkn760
-
Jin S, Li Y, Pan R, Zou X, 2014: Characterizing and controlling the inflammatory network during influenza A virus infection[J]. Sci Rep, 4, 3799-.
-
Johnson TR, Parker RA, Johnson JE, Graham BS, 2003: IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge[J]. J Immunol, 170, 2037-2045. doi: 10.4049/jimmunol.170.4.2037
-
Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE, 1969: An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine[J]. Am J Epidemiol, 89, 405-421. doi: 10.1093/oxfordjournals.aje.a120954
-
Knudson CJ, Hartwig SM, Meyerholz DK, Varga SM, 2015: RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets[J]. PLoS Pathog, 11, e1004757-. doi: 10.1371/journal.ppat.1004757
-
Lee DC, Harker JA, Tregoning JS, Atabani SF, Johansson C, Schwarze J, Openshaw PJ, 2010: CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection[J]. J Virol, 84, 8790-8798. doi: 10.1128/JVI.00796-10
-
Li C, Zhou X, Zhong Y, Li C, Dong A, He Z, Zhang S, Wang B, 2016: A recombinant G protein plus cyclosporine A-based respiratory syncytial virus vaccine elicits humoral and regulatory T cell responses against infection without vaccine-enhanced disease[J]. J Immunol, 196, 1721-1731. doi: 10.4049/jimmunol.1502103
-
Li Y, Jin S, Lei L, Pan Z, Zou X, 2015: Deciphering deterioration mechanisms of complex diseases based on the construction of dynamic networks and systems analysis[J]. Sci Rep, 5, 9283-. doi: 10.1038/srep09283
-
Liu X, Speranza E, Munoz-Fontela C, Haldenby S, Rickett NY, Garcia-Dorival I, Fang Y, Hall Y, Zekeng EG, Ludtke A, Xia D, Kerber R, Krumkamp R, Duraffour S, Sissoko D, Kenny J, Rockliffe N, Williamson ED, Laws TR, N'Faly M, Matthews DA, Gunther S, Cossins AR, Sprecher A, Connor JH, Carroll MW, Hiscox JA, 2017: Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus[J]. Genome Biol, 18, 4-. doi: 10.1186/s13059-016-1137-3
-
Loebbermann J, Durant L, Thornton H, Johansson C, Openshaw PJ, 2013: Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells[J]. Proc Natl Acad Sci USA, 110, 2987-2992. doi: 10.1073/pnas.1217580110
-
Moghaddam A, Olszewska W, Wang B, Tregoning JS, Helson R, Sattentau QJ, Openshaw PJ, 2006: A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines[J]. Nat Med, 12, 905-907. doi: 10.1038/nm1456
-
Murawski MR, McGinnes LW, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Heaton PM, Fraire AE, Morrison TG, 2010: Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology[J]. J Virol, 84, 1110-1123. doi: 10.1128/JVI.01709-09
-
Murphy BR, Prince GA, Walsh EE, Kim HW, Parrott RH, Hemming VG, Rodriguez WJ, Chanock RM, 1986: Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine[J]. J Clin Microbiol, 24, 197-202. doi: 10.1128/jcm.24.2.197-202.1986
-
Nepusz T, Yu H, Paccanaro A, 2012: Detecting overlapping protein complexes in protein-protein interaction networks[J]. Nat Methods, 9, 471-472. doi: 10.1038/nmeth.1938
-
Oughtred R, Stark C, Breitkreutz BJ, Rust J, Boucher L, Chang C, Kolas N, O'Donnell L, Leung G, McAdam R, Zhang F, Dolma S, Willems A, Coulombe-Huntington J, Chatr-Aryamontri A, Dolinski K, Tyers M, 2019: The BioGRID interaction database: 2019 update[J]. Nucleic Acids Res, 47, D529-D541. doi: 10.1093/nar/gky1079
-
Peng X, Gralinski L, Ferris MT, Frieman MB, Thomas MJ, Proll S, Korth MJ, Tisoncik JR, Heise M, Luo S, Schroth GP, Tumpey TM, Li C, Kawaoka Y, Baric RS, Katze MG, 2011: Integrative deep sequencing of the mouse lung transcriptome reveals differential expression of diverse classes of small RNAs in response to respiratory virus infection[J]. mBio, 2, e00198-11.
-
Polack FP, Teng MN, Collins PL, Prince GA, Exner M, Regele H, Lirman DD, Rabold R, Hoffman SJ, Karp CL, Kleeberger SR, Wills-Karp M, Karron RA, 2002: A role for immune complexes in enhanced respiratory syncytial virus disease[J]. J Exp Med, 196, 859-865. doi: 10.1084/jem.20020781
-
Qiao L, Zhang Y, Chai F, Tan Y, Huo C, Pan Z, 2016: Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection[J]. Antiviral Res, 131, 131-140. doi: 10.1016/j.antiviral.2016.05.001
-
Schuurhof A, Bont L, Pennings JL, Hodemaekers HM, Wester PW, Buisman A, de Rond LC, Widjojoatmodjo MN, Luytjes W, Kimpen JL, Janssen R, 2010: Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection[J]. J Virol, 84, 9584-9594. doi: 10.1128/JVI.00302-10
-
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T, 2003: Cytoscape: a software environment for integrated models of biomolecular interaction networks[J]. Genome Res, 13, 2498-2504. doi: 10.1101/gr.1239303
-
Shao HY, Yu SL, Sia C, Chen Y, Chitra E, Chen IH, Venkatesan N, Leng CH, Chong P, Chow YH, 2009: Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses[J]. Vaccine, 27, 5460-5471. doi: 10.1016/j.vaccine.2009.07.004
-
Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ, 2001: Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997[J]. J Infect Dis, 183, 16-22. doi: 10.1086/317655
-
Takeda S, Rodewald HR, Arakawa H, Bluethmann H, Shimizu T, 1996: MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span[J]. Immunity, 5, 217-228. doi: 10.1016/S1074-7613(00)80317-9
-
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K, 2003: Mortality associated with influenza and respiratory syncytial virus in the United States[J]. JAMA, 289, 179-186. doi: 10.1001/jama.289.2.179
-
Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L, 2013: Differential analysis of gene regulation at transcript resolution with RNA-seq[J]. Nat Biotechnol, 31, 46-53. doi: 10.1038/nbt.2450
-
van Diepen A, Brand HK, de Waal L, Bijl M, Jong VL, Kuiken T, van Amerongen G, van den Ham HJ, Eijkemans MJ, Osterhaus AD, Hermans PW, Andeweg AC, 2015: Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection[J]. J Virol, 89, 5022-5031. doi: 10.1128/JVI.03630-14
-
Varga SM, Wang X, Welsh RM, Braciale TJ, 2001: Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells[J]. Immunity, 15, 637-646. doi: 10.1016/S1074-7613(01)00209-6
-
Waris ME, Tsou C, Erdman DD, Zaki SR, Anderson LJ, 1996: Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern[J]. J Virol, 70, 2852-2860. doi: 10.1128/jvi.70.5.2852-2860.1996
-
Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, De Nardo D, Gohel TD, Emde M, Schmidleithner L, Ganesan H, Nino-Castro A, Mallmann MR, Labzin L, Theis H, Kraut M, Beyer M, Latz E, Freeman TC, Ulas T, Schultze JL, 2014: Transcriptome-based network analysis reveals a spectrum model of human macrophage activation[J]. Immunity, 40, 274-288. doi: 10.1016/j.immuni.2014.01.006
-
Yang B, Li M, Tang W, Liu W, Zhang S, Chen L, Xia J, 2018: Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma[J]. Nat Commun, 9, 678-. doi: 10.1038/s41467-018-03024-2
-
Yang J, Ma C, Zhao Y, Fan A, Zou X, Pan Z, 2020: Hepatitis B virus core particles containing a conserved region of the G protein combined with interleukin-35 protected mice against respiratory syncytial virus infection without vaccine-enhanced immunopathology[J]. J Virol, 94, e00007-20.
-
Zeng R, Zhang H, Hai Y, Cui Y, Wei L, Li N, Liu J, Li C, Liu Y, 2012: Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses[J]. J Virol, 86, 4505-4517. doi: 10.1128/JVI.07091-11
-
Zhang W, Xu J, Li Y, Zou X, 2019: Integrating network topology, gene expression data and GO annotation information for protein complex prediction[J]. J Bioinform Comput Biol, 17, 1950001-. doi: 10.1142/S021972001950001X
-
Zhang Y, Qiao L, Hu X, Zhao K, Zhang Y, Chai F, Pan Z, 2016: Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection[J]. Vaccine, 34, 252-260. doi: 10.1016/j.vaccine.2015.11.027